Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population

Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population

Item
http://www.wikidata.org/entity/Q36471425
Renal Cancer Stem Cells: Characterization and Targeted TherapiesCancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea AttentionStem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.Systems analysis of dynamic transcription factor activity identifies targets for treatment in Olaparib resistant cancer cells.In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.Cancer stem cell signaling pathways.The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives.Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.
P2860

Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population

Item
http://www.wikidata.org/entity/Q36471425
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@ast
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@en
type
label
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@ast
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@en
prefLabel
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@ast
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Treatment of Triple-Negative B ...... nt Cancer Stem Cell Population
@en
P2093
P2860
P304
P31
P356
10.1158/0008-5472.CAN-15-1640-T
P407
P433
P478
P50
P577
P698
P932